CC
AGN

ClearArc Capital’s Allergan plc AGN Stock Holding History

ClearArc Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$585K Sell
3,062
-1,434
-32% -$259K 0.23% 111
2019
Q3 		$757K Buy
4,496
+296
+7% +$48.2K 0.22% 109
2019
Q2 		$703K Sell
4,200
-598
-12% -$82.8K 0.21% 116
2019
Q1 		$702K Sell
4,798
-230
-5% -$33.3K 0.19% 128
2018
Q4 		$672K Sell
5,028
-2,340
-32% -$384K 0.2% 125
2018
Q3 		$1.4M Sell
7,368
-405
-5% -$74.4K 0.18% 123
2018
Q2 		$1.3M Buy
7,773
+255
+3% +$40.9K 0.18% 127
2018
Q1 		$1.26M Sell
7,518
-49
-0.6% -$8.22K 0.19% 128
2017
Q4 		$1.24M Buy
7,567
+9
+0.1% +$1.61K 0.17% 136
2017
Q3 		$1.55M Sell
7,558
-40
-0.5% -$9.3K 0.23% 101
2017
Q2 		$1.85M Buy
7,598
+22
+0.3% +$5.17K 0.3% 82
2017
Q1 		$1.81M Sell
7,576
-870
-10% -$203K 0.3% 81
2016
Q4 		$1.77M Sell
8,446
-525
-6% -$109K 0.32% 81
2016
Q3 		$2.07M Sell
8,971
-8
-0.1% -$1.96K 0.39% 62
2016
Q2 		$2.08M Buy
8,979
+34
+0.4% +$7.84K 0.4% 65
2016
Q1 		$2.4M Buy
8,945
+35
+0.4% +$10K 0.51% 49
2015
Q4 		$2.78M Buy
8,910
+82
+0.9% +$24.4K 0.58% 39
2015
Q3 		$2.4M Sell
8,828
-149
-2% -$45.8K 0.5% 48
2015
Q2 		$2.72M Buy
8,977
+1,064
+13% +$317K 0.5% 48
2015
Q1 		$2.35M Buy
7,913
+2,632
+50% +$750K 0.48% 51
2014
Q4 		$1.36M Buy
5,281
+208
+4% +$52K 0.28% 107
2014
Q3 		$1.22M Buy
5,073
+1,805
+55% +$404K 0.28% 107
2014
Q2 		$729K Buy
3,268
+11
+0.3% +$2.28K 0.17% 162
2014
Q1 		$670K Buy
3,257
+10
+0.3% +$1.98K 0.17% 164
2013
Q4 		$545K Sell
3,247
-29
-0.9% -$4.53K 0.14% 183
2013
Q3 		$472K Buy
3,276
+820
+33% +$109K 0.13% 188
2013
Q2 		$310K Buy
+2,456
New +$278K 0.08% 259

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ClearArc Capital's AGN Position: Q4 2019 in Review

ClearArc Capital reduced its Allergan plc (AGN) stake by 32% in Q4 2019, selling an estimated $259K and leaving 3,062 shares worth $585K. The position accounts for 0.23% of the portfolio, ranked #111.

ClearArc Capital first reported a position in AGN in Q2 2013 and has held it in 27 quarters since. The position peaked at $2.78M in Q4 2015. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • ClearArc Capital held 3,062 shares of Allergan plc worth $585K as of Q4 2019.
  • ClearArc Capital sold 1,434 Allergan plc shares in Q4 2019, an estimated $259K.
  • Allergan plc made up 0.23% of ClearArc Capital's portfolio in Q4 2019, its #111 holding.
  • ClearArc Capital first reported a position in Allergan plc in Q2 2013 and has held it in 27 quarters since.
  • ClearArc Capital's Allergan plc position peaked at $2.78M in Q4 2015.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.